We selected BIU-87 cells to evaluate the effect of down regulating TOP2A and KK47 cells to evaluate the effect of up regulating RRM1 to estimate the correlation between the expression of these two genes and tumour sensitivity to pirarubicin and gemcitabine (Figure 2B). Here, TOP2A is linked to neoplasm.